We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$9.16B
AUM Growth
-$13.2B
Cap. Flow
-$10.8B
Cap. Flow %
-117.92%
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657

Sector Composition

Rank Sector Weight
1 Technology 8.09%
2 Financials 7.11%
3 Healthcare 5.24%
4 Communication Services 5.21%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRE
1076
DELISTED
Veris Residential
VRE
$516K 0.01%
+34,660
New +$512K
REPL icon
1077
Replimune Group
REPL
$1.15B
$515K 0.01%
52,961
FWRD icon
1078
Forward Air
FWRD
$628M
$514K 0.01%
20,579
-14,320
-41% -$322K
COLD icon
1079
Americold
COLD
$4.13B
$512K 0.01%
39,811
+13,446
+51% +$165K
RAPP
1080
Rapport Therapeutics
RAPP
$2.34B
$509K 0.01%
+16,783
New +$464K
AIN icon
1081
Albany International
AIN
$1.79B
$504K 0.01%
9,939
+4,732
+91% +$245K
FRSH icon
1082
Freshworks
FRSH
$3.31B
$503K 0.01%
41,096
-38,501
-48% -$455K
ALHC icon
1083
Alignment Healthcare
ALHC
$2.74B
$502K 0.01%
25,401
-4,949
-16% -$88.9K
MUX icon
1084
McEwen Inc
MUX
$1.17B
$499K 0.01%
+26,970
New +$502K
SWBI icon
1085
Smith & Wesson
SWBI
$638M
$499K 0.01%
+50,529
New +$488K
MCHP icon
1086
Microchip Technology
MCHP
$44B
$498K 0.01%
7,823
-20,984
-73% -$1.29M
SMP icon
1087
Standard Motor Products
SMP
$889M
$498K 0.01%
+13,525
New +$519K
KSS icon
1088
Kohl's
KSS
$2.1B
$497K 0.01%
24,369
-18,611
-43% -$349K
PVH icon
1089
PVH
PVH
$3.91B
$497K 0.01%
7,413
-6,577
-47% -$514K
CSL icon
1090
Carlisle Companies
CSL
$15.5B
$495K 0.01%
1,549
-2,454
-61% -$795K
CHH icon
1091
Choice Hotels
CHH
$4.62B
$495K 0.01%
5,196
-12,081
-70% -$1.15M
TRDA icon
1092
Entrada Therapeutics
TRDA
$274M
$493K 0.01%
+47,967
New +$404K
DEFT
1093
Defi Technologies
DEFT
$188M
$490K 0.01%
650,000
-1,850,002
-74% -$2.83M
SR icon
1094
Spire
SR
$4.87B
$490K 0.01%
5,924
+2,230
+60% +$190K
VSAT icon
1095
Viasat
VSAT
$11.6B
$490K 0.01%
14,214
-31,338
-69% -$1.11M
BMI icon
1096
Badger Meter
BMI
$3.93B
$489K 0.01%
2,802
-10,409
-79% -$1.87M
NTAP icon
1097
NetApp
NTAP
$38.9B
$489K 0.01%
4,563
-3,960
-46% -$452K
ECG
1098
Everus Construction Group
ECG
$6.87B
$488K 0.01%
5,709
-1,808
-24% -$162K
VYX icon
1099
NCR Voyix
VYX
$1.11B
$485K 0.01%
47,548
+25,445
+115% +$276K
AHCO icon
1100
AdaptHealth
AHCO
$754M
$485K 0.01%
48,680
-132
-0.3% -$1.26K

Similar funds

Brevan Howard Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.

  • Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
  • Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
  • Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
  • Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
  • Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
  • Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
  • Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.